Vascular Biogenics Ltd

NASDAQ:VBLT   4:00:00 PM EDT
0.16
0.00 (0.00%)
7:50:47 PM EDT: $0.16 0.00 (0.00%)
Earnings Announcements

VBL Therapeutics Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:41 GMT
Vascular Biogenics Ltd (VBLT) - Vbl Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Vascular Biogenics Ltd- Qtrly Net Loss $9.2 Million, Or$0.12 per Share.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.